Study guide
6.2 Etiologies of Maternal Arrest & Structured Emergency Response
C-OBE Obstetric Emergencies Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems
1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics
2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing
3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion
3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)
4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features
4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia
5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy
5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management
6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean
6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)
7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States
7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive
8 Chapter 8: Acute Intrapartum Delivery Emergencies
8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols
9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma
9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections
10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections
11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies
11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)
12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies
12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration
13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications
13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol
14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity
14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies
6.2 Etiologies of Maternal Arrest & Structured Emergency Response
Key Takeaways Explain This Topic AI
The ACOG/AHA 'A-to-H' mnemonic systematically categorizes maternal cardiac arrest etiologies: Anesthesia, Bleeding/hemorrhage, Cardiovascular conditions, Drugs/toxicity, Embolic events (AFE/PE), Fever/sepsis, General non-obstetric causes (5 H's & 5 T's), and Hypertension/preeclampsia/eclampsia.
Local Anesthetic Systemic Toxicity (LAST) from inadvertent intravascular bupivacaine or ropivacaine injection requires immediate administration of 20% Lipid Emulsion (1.5 mL/kg IV bolus over 1 minute, followed by 0.25 mL/kg/min infusion; maximum total dose 12 mL/kg), while standard ACLS epinephrine doses must be reduced to <1 mcg/kg boluses and vasopressin avoided.
Amniotic Fluid Embolism (AFE) presents with the classic triad of sudden catastrophic hypoxemia/cyanosis, acute hemodynamic collapse/right heart failure, and fulminant consumptive coagulopathy/DIC; management centers on immediate aggressive cardiopulmonary stabilization, inotropic right-ventricular support, and massive transfusion protocol activation.
Structured obstetric code activation requires immediate multi-professional team mobilization with pre-assigned roles: Team Leader, Airway Specialist, Dedicated Chest Compressor, Continuous LUD Provider, Scribe/Timer, Obstetric Surgical Team for perimortem delivery, and Neonatal Resuscitation Program (NRP) team.
Magnesium sulfate toxicity causing respiratory arrest or asystole requires immediate cessation of infusion, airway protection, and prompt administration of 10% Calcium Gluconate (10 mL [1 g] IV over 2 to 5 minutes) or 10% Calcium Chloride (10 mL [1 g] IV).
Last updated: August 2026
Etiologies of Maternal Arrest & Structured Emergency Response
Identifying and treating the underlying cause of maternal cardiac arrest must occur concurrently with high-quality CPR and airway management. Unlike the non-pregnant population—where atherosclerotic coronary artery disease predominates—maternal arrest is driven by a unique spectrum of obstetric and non-obstetric pathologies. Rapid, structured diagnostic evaluation is vital for reversing arrest before irreversible hypoxic cellular death ensues.
1. The ACOG / AHA A-to-H Differential Diagnostic Framework
The American Heart Association and ACOG recommend utilizing the A-to-H mnemonic to guide rapid differential diagnosis and targeted resuscitative interventions: +---------------------------------------------------------------------------------------------------+
- | A-to-H MATERNAL CARDIAC ARREST MNEMONIC |
- | |
- | A • ANESTHESIA: High/total spinal block, Local Anesthetic Toxicity (LAST), failed intubation |
- | B • BLEEDING: Postpartum hemorrhage, uterine atony, placenta accreta spectrum, uterine rupture |
- | C • CARDIOVASCULAR: Peripartum cardiomyopathy, MI/SCAD, aortic dissection, arrhythmias |
- | D • DRUGS: Magnesium sulfate toxicity, illicit stimulants (cocaine/meth), opioids, anaphylaxis |
- | E • EMBOLIC: Amniotic Fluid Embolism (AFE), Pulmonary Embolism (PE), venous air embolism |
- | F • FEVER / INFECTION: Septic shock (chorioamnionitis, pyelonephritis, necrotizing fasciitis) |
- | G • GENERAL: Non-obstetric arrest etiologies (The standard 5 H's and 5 T's) |
- | H • HYPERTENSION: Preeclampsia with severe features, eclampsia, intracranial hemorrhage, PRES |
- +---------------------------------------------------------------------------------------------------+
- 2. In-Depth Clinical Evaluation of Critical Etiologies
- A — Anesthesia Complications & Local Anesthetic Systemic Toxicity (LAST)
High / Total Spinal Block: Precipitated by cephalad spread of local anesthetic or accidental subdural/subarachnoid injection during epidural placement. Manifests as sudden profound hypotension, ascending motor block (numbness in upper extremities/hands), intercostal paralysis, bradycardia (loss of cardioaccelerator fibers T1–T4), and respiratory arrest.
Management: Immediate 100% O2, endotracheal intubation, rapid IV fluid bolus, ephedrine (5–10 mg IV) or phenylephrine (50–100 mcg IV), and epinephrine if pulseless.
Local Anesthetic Systemic Toxicity (LAST): Accidental intravascular injection of amino-amide local anesthetics (e.g., bupivacaine, ropivacaine, lidocaine ) into epidural venous plexuses. Bupivacaine has high lipid solubility and strong affinity for cardiac voltage-gated sodium channels, causing refractory myocardial depression, conduction block, and ventricular arrhythmias. +---------------------------------------------------------------------------------------------------+
- | ASRA / SOAP LAST MANAGEMENT PROTOCOL |
- | |
- | 1. STOP LOCAL ANESTHETIC INJECTION IMMEDIATELY. |
- | 2. SECURE AIRWAY: 100% O2; prevent hypoxia, hypercapnia, and acidosis (acidosis worsens LAST). |
- | 3. ADMINISTER 20% LIPID EMULSION (INTRALIPID) STAT: |
- | • INITIAL BOLUS: **1.5 mL/kg IV over 1 minute** (approx. 100 mL for 70 kg adult). |
- | • CONTINUOUS INFUSION: **0.25 mL/kg/min** (approx. 18 mL/min for 70 kg adult). |
- | • REPEAT BOLUS: If hemodynamic instability persists, re-bolus 1.5 mL/kg once or twice every |
- | 3 to 5 minutes, and increase infusion to 0.5 mL/kg/min. |
- | • MAXIMUM DOSE: **12 mL/kg** in the initial 30 to 60 minutes. |
- | 4. ACLS MODIFICATIONS FOR LAST ARREST: |
- | • Reduce standard Epinephrine doses: Use small boluses (<1 mcg/kg; e.g., 10 to 100 mcg). |
- | • AVOID Vasopressin, Calcium Channel Blockers, Beta-Blockers, and Local Anesthetics (Lidocaine)|
- +---------------------------------------------------------------------------------------------------+
- B — Bleeding & Obstetric Hemorrhage
Severe postpartum hemorrhage (PPH) is a leading cause of hypovolemic/hemorrhagic shock and maternal arrest. Common etiologies include uterine atony (70%), placenta accreta spectrum (PAS), placental abruption, uterine rupture, and genital tract lacerations.
Resuscitation Priorities:
Activate Massive Transfusion Protocol (MTP) : Transfuse uncrossed O-negative/type-specific blood in balanced 1:1:1 ratio (Packed Red Blood Cells : Fresh Frozen Plasma : Platelets).
Administer Tranexamic Acid (TXA) : 1 g IV over 10 minutes within 3 hours of bleeding onset; second dose of 1 g IV if bleeding persists after 30 minutes.
Bimanual uterine compression, intrauterine balloon tamponade (e.g., Bakri balloon), uterine artery embolization, or emergency surgical interventions (B-Lynch sutures, bilateral uterine artery ligation, emergent peripartum hysterectomy).
C — Cardiovascular Conditions
Cardiovascular conditions account for >26% of all pregnancy-related deaths:
Peripartum Cardiomyopathy (PPCM): Idiopathic heart failure with reduced ejection fraction (LVEF <45%) presenting in the last month of pregnancy or first 5 months postpartum. Presents with acute pulmonary edema, cardiogenic shock, and ventricular arrhythmias.
Spontaneous Coronary Artery Dissection (SCAD) & Acute MI: Pregnancy-induced hormonal wall remodeling and hemodynamic shear stress predispose parturients to non-atherosclerotic SCAD, most commonly affecting the Left Anterior Descending (LAD) artery. Avoid aggressive stenting unless flow is completely compromised.
Aortic Dissection: Associated with Marfan syndrome, Turner syndrome, vascular Ehlers-Danlos, and severe preeclampsia. Presenting with tearing chest/back pain; requires emergency CT angiography and cardiothoracic surgical intervention.
D — Drugs & Toxicity
Magnesium Sulfate Toxicity: High-dose MgSO4 infusion for severe preeclampsia/eclampsia or neuroprotection can lead to hypermagnesemia:
Serum Mg 4.8–8.4 mg/dL (4–7 mEq/L): Therapeutic range.
Serum Mg 8.4–12 mg/dL (7–10 mEq/L): Loss of deep tendon reflexes (patellar DTRs).
Serum Mg 12–14.4 mg/dL (10–12 mEq/L): Respiratory depression and hypoventilation.
Serum Mg >18 mg/dL (>15 mEq/L): Sinoatrial and atrioventricular heart block, cardiac arrest.
Antidote: 10% Calcium Gluconate 10 mL (1 g) IV over 2 to 5 minutes , or 10% Calcium Chloride 10 mL (1 g) IV ; intubate for respiratory failure.
Opioid Toxicity: Administer Naloxone 0.4 to 2 mg IV/IO , repeated every 2 to 3 minutes.
E — Embolic Events: Amniotic Fluid Embolism (AFE) & Pulmonary Embolism (PE)
Amniotic Fluid Embolism (AFE / Anaphylactoid Syndrome of Pregnancy): An unpredictable, immune-mediated, catastrophic reaction triggered by the entry of fetal antigens/amniotic fluid into the maternal venous circulation. +---------------------------------------------------------------------------------------------------+
- | AFE CLINICAL PRESENTATION & RESUSCITATION PROTOCOL |
- | |
- | CLASSIC TRIAD OF AFE: |
- | 1. Sudden, profound hypoxemia / acute respiratory failure (cyanosis, dyspnea, SpO2 <80%). |
- | 2. Acute hemodynamic collapse (severe hypotension, right ventricular failure, cardiac arrest). |
- | 3. Fulminant consumptive coagulopathy / DIC with massive hemorrhage within 30 to 60 minutes. |
- | |
- | PATHOPHYSIOLOGY & MANAGEMENT: |
- | • Phase 1: Transient intense pulmonary vasospasm -> acute right ventricular failure -> arrest. |
- | • Phase 2: Left ventricular failure, non-cardiogenic pulmonary edema, and DIC with hyperfibrinolysis.|
- | • Supportive Resuscitation: Immediate intubation, inotropes (Norepinephrine, Epinephrine, |
- | Milrinone/Vasopressin for RV afterload reduction), MTP, and Cryoprecipitate/Fibrinogen. |
- | • 'A-OK' Novel Regimen (Investigational adjunct): Atropine (0.8–1 mg) to block vagal reflex, |
- | Ondansetron (8 mg) to block serotonin receptors, Ketorolac (30 mg) to inhibit thromboxane. |
- | • Extracorporeal Membrane Oxygenation (VA-ECMO): Indicated for refractory cardiogenic shock. |
- +---------------------------------------------------------------------------------------------------+
Pulmonary Embolism (PE): Hypercoagulability of pregnancy increases VTE risk 4- to 5-fold. Massive PE causing cardiac arrest warrants immediate Systemic Thrombolysis (Alteplase / tPA 50 to 100 mg IV infusion/bolus) during CPR, or emergent surgical/catheter-directed embolectomy.
F — Fever & Maternal Sepsis
Septic shock from chorioamnionitis, septic abortion, pyelonephritis, or Group A Streptococcus necrotizing fasciitis requires early recognition using the Obstetric Modified SOFA score. Resuscitation bundles mandate:
Measure serum lactate.
Blood cultures prior to antibiotics.
Administer broad-spectrum empiric IV antibiotics (e.g., Ampicillin, Gentamicin, Clindamycin / Meropenem) within 1 hour .
Rapid IV crystalloid infusion ( 30 mL/kg within 3 hours ).
Norepinephrine as first-line vasopressor to maintain MAP >=65 mmHg.
G — General Non-Obstetric Causes (5 H's and 5 T's)
Standard reversible ACLS etiologies must be investigated: Hypovolemia , Hypoxia , Hydrogen ion (acidosis) , Hypo/Hyperkalemia , Hypothermia ; and Tension pneumothorax (immediate needle decompression/thoracostomy), Tamponade (cardiac) , Toxins , Thrombosis (pulmonary) , Thrombosis (coronary) .
H — Hypertension, Preeclampsia & Eclampsia
Severe preeclampsia can precipitate hemorrhagic stroke (intracranial hemorrhage is the single most common cause of death in preeclampsia), hypertensive encephalopathy, Posterior Reversible Encephalopathy Syndrome (PRES), acute pulmonary edema, or subcapsular hepatic hematoma rupture. First-line urgent antihypertensives (IV Labetalol, IV Hydralazine, oral immediate-release Nifedipine) and seizure prophylaxis (IV Magnesium Sulfate) are vital.